PTC Therapeutics
PTCT
#3055
Rank
C$7.42 B
Marketcap
C$88.92
Share price
-1.06%
Change (1 day)
-1.63%
Change (1 year)

PTC Therapeutics (PTCT) - Net assets

Net assets on the balance sheet as of June 2026 : -C$0.24 Billion

According to PTC Therapeutics 's latest financial reports the company has -C$0.24 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

PTC Therapeutics - Net assets on balance sheet (from 2012 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-C$0.29 Billion-82.16%
2024-12-31$-C$1.58 Billion45.13%
2023-12-31$-C$1.09 Billion130.52%
2022-12-31$-C$0.48 Billion-25799.38%
2021-12-31$C$1.83 M-99.7%
2020-12-31$C$0.61 B-20.83%
2019-12-31$C$0.77 B62.47%
2018-12-31$C$0.47 B142.91%
2017-12-31$C$0.19 B22.39%
2016-12-31$C$0.16 B-48.74%
2015-12-31$C$0.31 B-9.49%
2014-12-31$C$0.34 B138.3%
2013-12-31$C$0.14 B-861.51%
2012-12-31$-C$19.09 Million-92.14%
2011-12-31$-C$0.25 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
C$59.62 B-25,466.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
C$28.78 B-12,344.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C$0.71 B-404.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$2.17 B-1,023.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
C$0.21 B-192.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
C$2.40 B-1,121.15%๐Ÿ‡บ๐Ÿ‡ธ USA